What Medication Treats Cavernoma? Exploring Current and Future Therapies
•
4 min read
Affecting approximately 1 in every 500 people, cerebral cavernous malformations (CCM), or cavernomas, are abnormal clusters of thin-walled blood vessels in the brain and spinal cord. While no FDA-approved medication exists to directly cure cavernoma lesions, ongoing research is exploring targeted therapies to manage bleeding and stabilize these lesions.